A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis

NCT06327295 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Onychomycosis

Interventions

DRUG: ATB1651-102- Cohort 1
DRUG: ATB1651-102- Cohort 2
DRUG: ATB1651-102- Cohort 3
DRUG: ATB1651-102- Cohort 4
DRUG: Placebo

Sponsor

AmtixBio Co., Ltd.